NCT07082894

Brief Summary

This prospective randomized controlled study will be conducted to evaluate the effects of preoperative oral magnesium on the incidence and severity of emergence agitation in children undergoing adenotonsillectomy using sevoflurane anesthesia.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 5, 2025

Completed
19 days until next milestone

First Posted

Study publicly available on registry

July 24, 2025

Completed
1 day until next milestone

Study Start

First participant enrolled

July 25, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 22, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 22, 2026

Completed
Last Updated

July 28, 2025

Status Verified

July 1, 2025

Enrollment Period

6 months

First QC Date

July 5, 2025

Last Update Submit

July 25, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence of emergence agitation

    Pediatric Anesthesia Emergence Delirium scale scores will be used and a score ≥ 10 will be considered to be a diagnostic endpoint for the development of agitation. It will be assessed on arrival to the post anesthesia care unit (PACU), and every 15 min thereafter for 1 hour

    Up to 1 hour after surgery.

Secondary Outcomes (6)

  • Parental separation anxiety

    Perioperative

  • Mask Acceptance Score

    Perioperative

  • Postoperative pain

    Up to 1 hour after surgery.

  • Total dose of rescue fentanyl

    Up to 1 hour after surgery.

  • Pediatric Anesthesia Emergence Delirium scale scores

    Up to 1 hour after surgery.

  • +1 more secondary outcomes

Study Arms (2)

Magnesium group

EXPERIMENTAL

cases will receive preoperative oral magnesium dose of 120 mg at one hour before surgery

Drug: Magnesium

Control group

PLACEBO COMPARATOR

cases will receive oral lemon juice at one hour before surgery.

Other: Placebo control

Interventions

preoperative oral magnesium dose of 120 mg at one hour before surgery will be given.

Magnesium group

preoperative oral lemon juice at one hour before surgery will be given.

Control group

Eligibility Criteria

Age4 Years - 7 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Both gender
  • to 7 years age
  • American Society of Anesthesiologists (ASA) Physical Status I or II
  • Scheduled for adenotonsillectomy surgery under sevoflurane anesthesia

You may not qualify if:

  • Parents declined to participate in the trial
  • Children with behavioral changes; neurological or psychiatric diseases
  • Physical or developmental delay
  • Sedative or anticonvulsant medication
  • Pre-existing renal or cardiovascular disease, bone disease, or gastrointestinal disorders
  • Allergy to magnesium

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tanta University

Tanta, Gharbia Governorate, 31527, Egypt

RECRUITING

MeSH Terms

Conditions

Emergence Delirium

Interventions

Magnesium

Condition Hierarchy (Ancestors)

DeliriumConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Metals, Alkaline EarthElementsInorganic ChemicalsMetals, LightMetals

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
double blinded
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Parallel assignment
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer of anesthesiology, surgical intensive care and pain medicine

Study Record Dates

First Submitted

July 5, 2025

First Posted

July 24, 2025

Study Start

July 25, 2025

Primary Completion

January 22, 2026

Study Completion

January 22, 2026

Last Updated

July 28, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will share

The data will be available upon a reasonable request from the corresponding author

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
The data will be available upon a reasonable request from the corresponding author after the end of the study for 1 year
Access Criteria
The data will be available upon a reasonable request from the corresponding author

Locations